BridgeBio Pharma, Inc. (BBIO)
72.31
-0.84
(-1.15%)
USD |
NASDAQ |
Apr 06, 16:00
72.31
0.00 (0.00%)
After-Hours: 16:00
BridgeBio Pharma SG&A Expense (TTM) : 531.22M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 13.79B |
| Insmed, Inc. | 701.17M |
| Mirum Pharmaceuticals, Inc. | 257.03M |
| Supernus Pharmaceuticals, Inc. | 485.56M |
| Apellis Pharmaceuticals, Inc. | 550.26M |